Literature DB >> 699921

Maple syrup urine disease: treatment of the acutely ill newborn.

G Hammersen, L Wille, H Schmidt, P Lutz, H Bickel.   

Abstract

Three patients with maple syrup urine disease were treated during the acute neonatal stage. Multiple exchange transfusions proved to be a satisfactory means of achieving rapid clinical and biochemical improvement during this phase. On the other hand, evidence is provided suggesting that in addition to exchange transfusions, a high calorie intake above 150 Cal/kg body weight/day is necessary to lower the plasma concentration of the branched chain amino acids to near-normal levels. As long as this calorie intake was not provided, further exchange transfusions failed to lower the plasma leucine concentration to below 17 mg/100 ml in one patient. It is assumed that this high calorie intake is necessary to prevent the breakdown of endogenous protein. Treatment of acute episodes in maple syrup urine disease should therefore not only eliminate the elevated alpha-keto acids and branched chain amino acids quickly (i.e. by multiple exchange transfusions or peritoneal dialysis), but in addition should provide a high calorie intake.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699921     DOI: 10.1007/bf00442159

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  LATE MANIFESTING VARIANT OF BRANCHED-CHAIN KETOACIDURIA (MAPLE SYRUP URINE DISEASE).

Authors:  R KIIL; T ROKKONES
Journal:  Acta Paediatr       Date:  1964-07       Impact factor: 2.299

2.  Maple syrup urine disease: branched-chain keto-aciduria.

Authors:  J DANCIS; M LEVITZ; R G WESTALL
Journal:  Pediatrics       Date:  1960-01       Impact factor: 7.124

3.  The amino acid requirements of man. VI. The rôle of the caloric intake.

Authors:  W C ROSE; M J COON; G F LAMBERT
Journal:  J Biol Chem       Date:  1954-09       Impact factor: 5.157

4.  Maple syrup urine disease: rapid prenatal diagnosis by enzyme assay.

Authors:  U Wendel; H W Rüdiger; E Passarge; M Mikkelsen
Journal:  Humangenetik       Date:  1973

5.  Maple syrup urine disease variant: report on an infant.

Authors:  P Koepp; C Rybak; H W Rüdiger; U Wendel
Journal:  Z Kinderheilkd       Date:  1974-02-11

6.  Family with intermittent maple syrup urine disease.

Authors:  H B Valman; A D Patrick; J W Seakins; J W Platt; D Gompertz
Journal:  Arch Dis Child       Date:  1973-03       Impact factor: 3.791

7.  Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.

Authors:  L Schuchmann; I Witt; P Schulz; H Schumacher; H Rüdiger
Journal:  Helv Paediatr Acta       Date:  1972-09

8.  Enzyme activity in classical and variant forms of maple syrup urine disease.

Authors:  J Dancis; J Hutzler; S E Snyderman; R P Cox
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

9.  [Maple syrup urine disease with an intermittent relatively benign course].

Authors:  H Müller; H Bickel; D Feist; P Lutz
Journal:  Dtsch Med Wochenschr       Date:  1971-10       Impact factor: 0.628

10.  [Emergency treatment of an acute form of leucinosis by peritoneal dialysis].

Authors:  F Rey; J Rey; M Cloup; J F Féron; F Doré; B Labrune; J Frézal
Journal:  Arch Fr Pediatr       Date:  1969-02
View more
  5 in total

1.  Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.

Authors:  U Wendel; K Becker; H Przyrembel; M Bulla; C Manegold; A Mench-Hoinowski; U Langenbeck
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

2.  Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update.

Authors:  J M Saudubray; H Ogier; C Charpentier; E Depondt; F X Coudé; A Munnich; G Mitchell; F Rey; J Rey; J Frézal
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

Review 3.  Animal models of maple syrup urine disease.

Authors:  K J Skvorak
Journal:  J Inherit Metab Dis       Date:  2009-03-09       Impact factor: 4.982

4.  Maple syrup urine disease--therapeutic use of insulin in catabolic states.

Authors:  U Wendel; U Langenbeck; I Lombeck; H J Bremer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

5.  Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids.

Authors:  U Wendel; U Langenbeck; I Lombeck; H J Bremer
Journal:  Eur J Pediatr       Date:  1982-07       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.